Trial Profile
Evaluating the Safety and Efficacy of S-1+CDDP in Patients With Recurrent, Metastatic, or Unresectable Gastric Cancer.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 24 Apr 2016
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin; Fluorouracil
- Indications Gastric cancer
- Focus Therapeutic Use
- 03 Jun 2010 New trial record